Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform
Lung cancer remains a major therapeutic challenge, particularly when tumors resist targeted therapy or checkpoint blockade. Vaccinia virus (VV), historically used as a vaccine vector, is now being repurposed to selectively kill tumor cells while activating antitumor immunity. Beyond direct oncolysis...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-05-01
|
| Colección: | Frontiers in Immunology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1797922/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|